Vincenzo Libri is a Professor of Translational Neurology at UCL-Institute of Neurology (ION) and Honorary Consultant Clinical Pharmacologist at UCLH-National Hospital for Neurology and Neurosurgery (NHNN). He is Director of the NIHR Clinical Research Facility at UCLH; Director of the Masters in Translational Neuroscience at UCL; Chair of the Health Research Authority-Hampshire B Research Ethics Committee and Fellow of the Royal College of Physicians (FRCP) and British Pharmacological Society (FBPhS). 

Prof Libri obtained his MD degree and Specialist Training in Clinical Pharmacology in Italy in 1985 and 1989, respectively. Between 1990-1998 he was a Wellcome Trust and MRC Grant Holder at the Department of Pharmacology, The School of Pharmacy, London-UK. He was  Lecturer in Pharmacology at the University of Rome, Italy, between 1994-1998. From 1998 to 2008 he worked in multiple Pharmaceutical Companies (GlaxoWellcome, Eli Lilly and GlaxoSmithKline), undertaking direct responsibility and leadership for translational medicine and early phase clinical trials across diseases. From 2009 to 2013 he was Head of Clinical Studies at the NIHR Clinical Research Facility, Imperial College London, overseeing the running of the Centre and managing the whole portfolio of clinical studies. In October 2013 he was appointed founding Head of the Leonard Wolfson Experimental Medicine Centre (LWENC) at UCL-ION under a major capital award from the Wolfson Foundation. Under his leadership, the Centre progressively increased its reputation and it is now recognised worldwide as an established Centre of Excellence in neurodegeneration research and a major asset for complex early phase clinical trials. In April 2016, he took up the role of Director of the NIHR UCLH Clinical Research Facility to amalgamate it with the LWENC in a single, integrated CRF at two sites, under a common leadership and teamwork. 

Prof Libri  is a member of several internal and external research committees and boards, including the UCLH/UCL BRC Executive Board; the UCL Institute for Precision Medicine Steering Committee, the CTIMP Sponsorship Committee at GOSH; the Alzheimer's Research UK Global Clinical Trials Advisory Panel, the MHRA-HRA-Dept of Health-NIHR CRF Directors Board for Phase-I clinical trials; the Biogen Neuro-Network Advisory Board for FIH trials in neurological disorders, the NIHR Southampton CRF Early Phase Safety Committee, the Covid-19 North Thames Clinical Research Network, etc. He is external referee/assessor of several funding schemes for research, fellowships and infrastructure awards, including the ARUK Global Clinical Trials Fund for early phase clinical trials in Dementia, the ICM (Institut du Cerveau et de la Moelle épinière, Paris, Fr)- ICRIN (Clinical Research Infrastructures in Neurosciences) Award, the MIUR (Italian Ministry of Education, University and Research)-PRIN (Research Projects of National Interest) Referee Evaluation Panel and others.